Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 19-23, January 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schoenmakers, E. F. P. M.
Right arrow Articles by Van de Ven, W. J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schoenmakers, E. F. P. M.
Right arrow Articles by Van de Ven, W. J. M.
[Cancer Research 59, 19-23, January 1, 1999]
© 1999 American Association for Cancer Research


Advances in Brief

Allelic Knockout of Novel Splice Variants of Human Recombination Repair Gene RAD51B in t(12;14) Uterine Leiomyomas1

Eric F. P. M. Schoenmakers2, Christel Huysmans and Wim J. M. Van de Ven

Laboratory for Molecular Oncology, Center for Human Genetics, University of Leuven, and Flanders Interuniversity Institute for Biotechnology, B-3000 Leuven, Belgium

Recently, the high mobility group protein gene HMGIC was identified as the chromosome 12q15 target gene in a variety of benign solid tumors. Here, we report that the recombinational repair gene RAD51B on chromosome 14q23–24 is the preferential translocation partner of HMGIC in uterine leiomyomas. The pathogenetically critical sequences seem to reside in the last coding exon of a novel RAD51B isoform, which encode a domain containing a putative transmembrane anchor and are expressed in the uterus but not in a wide variety of other tissues tested. By fluorescence in situ hybridization, rapid amplification of 3' cDNA ends, and reverse transcription-PCR analysis, we demonstrated consistent chromosomal rearrangements within RAD51B and expression of fusion transcripts, structurally resulting in an allelic knockout of the uterine isoform of RAD51B and confirming a pleiotropic function of this gene.




This article has been cited by other articles:


Home page
ScienceHome page
C. Mayr, M. T. Hemann, and D. P. Bartel
Disrupting the Pairing Between let-7 and Hmga2 Enhances Oncogenic Transformation
Science, March 16, 2007; 315(5818): 1576 - 1579.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
O. Date, M. Katsura, M. Ishida, T. Yoshihara, A. Kinomura, T. Sueda, and K. Miyagawa
Haploinsufficiency of RAD51B Causes Centrosome Fragmentation and Aneuploidy in Human Cells.
Cancer Res., June 15, 2006; 66(12): 6018 - 6024.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
E. A. Stewart and C. C. Morton
The genetics of uterine leiomyomata: what clinicians need to know.
Obstet. Gynecol., April 1, 2006; 107(4): 917 - 921.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
A. M. Gruver, K. A. Miller, C. Rajesh, P. G. Smiraldo, S. Kaliyaperumal, R. Balder, K. M. Stiles, J. S. Albala, and D. L. Pittman
The ATPase motif in RAD51D is required for resistance to DNA interstrand crosslinking agents and interaction with RAD51C
Mutagenesis, November 1, 2005; 20(6): 433 - 440.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. E. Bulun, Z. Lin, G. Imir, S. Amin, M. Demura, B. Yilmaz, R. Martin, H. Utsunomiya, S. Thung, B. Gurates, et al.
Regulation of Aromatase Expression in Estrogen-Responsive Breast and Uterine Disease: From Bench to Treatment
Pharmacol. Rev., September 1, 2005; 57(3): 359 - 383.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. Mohindra, E. Bolderson, J. Stone, M. Wells, T. Helleday, and M. Meuth
A tumour-derived mutant allele of XRCC2 preferentially suppresses homologous recombination at DNA replication forks
Hum. Mol. Genet., January 15, 2004; 13(2): 203 - 212.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
L. Borrmann, R. Schwanbeck, T. Heyduk, B. Seebeck, P. Rogalla, J. Bullerdiek, and J. R. Wisniewski
High mobility group A2 protein and its derivatives bind a specific region of the promoter of DNA repair gene ERCC1 and modulate its activity
Nucleic Acids Res., December 1, 2003; 31(23): 6841 - 6851.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. J. Quade, S. Weremowicz, D. M. Neskey, R. Vanni, C. Ladd, P. Dal Cin, and C. C. Morton
Fusion Transcripts Involving HMGA2 Are not a Common Molecular Mechanism in Uterine Leiomyomata with Rearrangements in 12q15
Cancer Res., March 15, 2003; 63(6): 1351 - 1358.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Yokoyama, H. Kurumizaka, S. Ikawa, S. Yokoyama, and T. Shibata
Holliday Junction Binding Activity of the Human Rad51B Protein
J. Biol. Chem., January 17, 2003; 278(4): 2767 - 2772.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Shozu, H. Sumitani, T. Segawa, H.-J. Yang, K. Murakami, T. Kasai, and M. Inoue
Overexpression of Aromatase P450 in Leiomyoma Tissue Is Driven Primarily through Promoter I.4 of the Aromatase P450 Gene (CYP19)
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2540 - 2548.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
E. Roijer, A. Nordkvist, A.-K. Strom, W. Ryd, M. Behrendt, J. Bullerdiek, J. Mark, and G. Stenman
Translocation, Deletion/Amplification, and Expression of HMGIC and MDM2 in a Carcinoma ex Pleomorphic Adenoma
Am. J. Pathol., February 1, 2002; 160(2): 433 - 440.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J.-Y. Masson, A. Z. Stasiak, A. Stasiak, F. E. Benson, and S. C. West
Complex formation by the human RAD51C and XRCC3 recombination repair proteins
PNAS, July 17, 2001; 98(15): 8440 - 8446.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Takata, M. S. Sasaki, S. Tachiiri, T. Fukushima, E. Sonoda, D. Schild, L. H. Thompson, and S. Takeda
Chromosome Instability and Defective Recombinational Repair in Knockout Mutants of the Five Rad51 Paralogs
Mol. Cell. Biol., April 15, 2001; 21(8): 2858 - 2866.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
H. Sumitani, M. Shozu, T. Segawa, K. Murakami, H.-J. Yang, K. Shimada, and M. Inoue
In Situ Estrogen Synthesized by Aromatase P450 in Uterine Leiomyoma Cells Promotes Cell Growth Probably Via an Autocrine/Intracrine Mechanism
Endocrinology, October 1, 2000; 141(10): 3852 - 3861.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Takata, M. S. Sasaki, E. Sonoda, T. Fukushima, C. Morrison, J. S. Albala, S. M. A. Swagemakers, R. Kanaar, L. H. Thompson, and S. Takeda
The Rad51 Paralog Rad51B Promotes Homologous Recombinational Repair
Mol. Cell. Biol., September 1, 2000; 20(17): 6476 - 6482.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. Tanaka, T. Hiramoto, T. Fukuda, and K. Miyagawa
A Novel Human Rad54 Homologue, Rad54B, Associates with Rad51
J. Biol. Chem., August 18, 2000; 275(34): 26316 - 26321.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.